Because the
patient is not required to make frequent visits to a Hemodialysis clinic, a patient on
Peritoneal Dialysis may experience much less disruption to life than a patient on Hemodialysis.
However, the risk of infections leading to episodes of peritonitis, a bacterial infection
of the peritoneum, can limit Peritoneal Dialysis. In addition, patients using Peritoneal
Dialysis must have some residual renal function. Both factors limit Peritoneal Dialysis as
a long-term therapy for some patients. Therefore, in general, patients with end-stage
renal disease require Hemodialysis treatment at some point during the course of their
disease.
Hemodialysis is the more
frequently used treatment; approximately 85% of the worldwide patient population are
treated with Hemodialysis while 15% are on Peritoneal Dialysis. Yet, depending on different factors
such as status of the medical infrastructure and reimbursement differences for treatment,
there are significant differences in the utilization of Hemodialysis and Peritoneal Dialysis in various countries. |